Robert Hermans
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Robert Hermans has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
G Marchal
5 shared publicationsA L Baert
3 shared publicationsF. De Keyzer
3 shared publicationsM. Lambrecht
3 shared publicationsP Delaere
3 shared publicationsS. Nuyts
3 shared publications
Latest Publications
- Open Access
- 5 May 2015
- Vol. 2 (2) , 138-139
Tumour oxygenation measurements using computed tomography and magnetic resonance imaging
- 5 May 2015
- Vol. 2 (2) , 138-139
Open AccessTumour oxygenation measurements using computed tomography and magnetic resonance imaging
- 1 February 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 114
PO-139: Photodynamic therapy as an adjuvant treatment after TORS of recurrent SCC of the base of tongue
- 1 February 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 114
PO-139: Photodynamic therapy as an adjuvant treatment after TORS of recurrent SCC of the base of tongue
- 1 February 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106, S9
PD-024: The use of Sequential Diffusion Weighted MRI in the Early Prediction of Volumetric Changes During Radiotherapy
- 1 February 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106, S9
PD-024: The use of Sequential Diffusion Weighted MRI in the Early Prediction of Volumetric Changes During Radiotherapy
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S73-S74
OC-0190 VISUALIZING TREATMENT RESISTANT REGIONS WITHIN THE TUMOR USING SEQUENTIAL DWI: CLINICAL VALIDATION
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S73-S74
OC-0190 VISUALIZING TREATMENT RESISTANT REGIONS WITHIN THE TUMOR USING SEQUENTIAL DWI: CLINICAL VALIDATION
- 1 January 2012
- Vol. 8 (2) , 113-21
Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease.
We reviewed our experience with MTC (medullary thyroid cancer), focusing on recurrence and survival, recommendations for the extent of lymph node (LN) dissection and surgery for recurrent disease. Of 51 MTC patients treated between 1988 and 2008 at the University Hospitals Leuven, 38 previously untreated patients were analysed. Overall and disease-specific (DSS) five-year survival rates were 75% and 82%. Variables univariately associated with DSS were age, pN, stage, vascular invasion, pre-operative recurrent laryngeal nerve function and last calcitonin level. Recurrence occurred in 10 patients (26%). For recurrence, age was no longer a prognostic factor and post-operative calcitonin, number of positive LN and of positive compartments proved to be prognostic factors. Of 21 clinical NO patients, 2 out of 6 (33%) undergoing a prophylactic central neck dissection (ND) based on per-operative palpatory suspicion proved pN+, and 2 out of 9 patients (22%) undergoing a prophylactic lateral ND were pN+. Five patients surgically treated for recurrence did not achieve long-term normalisation of calcitonin, but remained alive with locoregional control. Overall survival and DSS rates are within the range reported in the literature. The results confirm that (1) total thyroidectomy and central compartment dissection is the treatment of choice in the cN0 patients, (2) additional ipsilateral lateral ND is needed for cN+ disease in the ipsilateral lateral compartment, and (3) in the clinically uninvolved contralateral lateral neck, per-operative inspection should serve as a basis for a decision about further ND. Locoregional control and prolonged survival is achieved in surgically treated locoregionally recurrent MTC.
- 1 January 2012
- Vol. 8 (2) , 113-21
Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease.
We reviewed our experience with MTC (medullary thyroid cancer), focusing on recurrence and survival, recommendations for the extent of lymph node (LN) dissection and surgery for recurrent disease. Of 51 MTC patients treated between 1988 and 2008 at the University Hospitals Leuven, 38 previously untreated patients were analysed. Overall and disease-specific (DSS) five-year survival rates were 75% and 82%. Variables univariately associated with DSS were age, pN, stage, vascular invasion, pre-operative recurrent laryngeal nerve function and last calcitonin level. Recurrence occurred in 10 patients (26%). For recurrence, age was no longer a prognostic factor and post-operative calcitonin, number of positive LN and of positive compartments proved to be prognostic factors. Of 21 clinical NO patients, 2 out of 6 (33%) undergoing a prophylactic central neck dissection (ND) based on per-operative palpatory suspicion proved pN+, and 2 out of 9 patients (22%) undergoing a prophylactic lateral ND were pN+. Five patients surgically treated for recurrence did not achieve long-term normalisation of calcitonin, but remained alive with locoregional control. Overall survival and DSS rates are within the range reported in the literature. The results confirm that (1) total thyroidectomy and central compartment dissection is the treatment of choice in the cN0 patients, (2) additional ipsilateral lateral ND is needed for cN+ disease in the ipsilateral lateral compartment, and (3) in the clinically uninvolved contralateral lateral neck, per-operative inspection should serve as a basis for a decision about further ND. Locoregional control and prolonged survival is achieved in surgically treated locoregionally recurrent MTC.
- 1 January 2011
- Published by Springer Nature
- p. 181-194
Parapharyngeal Space Neoplasms
- 1 January 2011
- Published by Springer Nature
- p. 147-162
Neoplasms of the Oropharynx
- 1 January 2011
- Published by Springer Nature
- p. 55-95
Laryngeal Neoplasms
- 1 January 2011
- Published by E-MED LTD in Cancer Imaging
- Vol. 11 (1A) , S112-S113
The prognostic value of pretherapeutic diffusion-weighted MRI in oropharyngeal carcinoma treated with (chemo-)radiotherapy
Scientific session, Tuesday 4 October 2011 - Cancer Imaging Scientific session, Tuesday 4 October 2011 - Article Metadata Article Ref: ci119055 Open Access: 0
- 1 January 2011
- Published by E-MED LTD in Cancer Imaging
- Vol. 11 (1A) , S112-S113
The prognostic value of pretherapeutic diffusion-weighted MRI in oropharyngeal carcinoma treated with (chemo-)radiotherapy
Scientific session, Tuesday 4 October 2011 - Cancer Imaging Scientific session, Tuesday 4 October 2011 - Article Metadata Article Ref: ci119055 Open Access: 0
- 1 January 2008
- Published by E-MED LTD in Cancer Imaging
- Vol. 8 (Special A) , S94-S107
Staging of laryngeal and hypopharyngeal cancer: value of imaging studies
Staging of laryngeal and hypopharyngeal cancer: value of imaging studies - Cancer Imaging Staging of laryngeal and hypopharyngeal cancer: value of imaging studies - Imaging methods assist in the pre-treatment planning of laryngeal and hypopharyngeal neoplasms, by better defining the local extension of infiltrating tumours and by detecting subclinical neck adenopathies. Imaging has also an important role in excluding or detecting distant metastasis. Furthermore, there is evidence that several imaging-derived parameters can be used as predictors of locoregional control after radiotherapy, and this independently from the TN classification.
- 1 January 2008
- Published by E-MED LTD in Cancer Imaging
- Vol. 8 (Special A) , S94-S107
Staging of laryngeal and hypopharyngeal cancer: value of imaging studies
Staging of laryngeal and hypopharyngeal cancer: value of imaging studies - Cancer Imaging Staging of laryngeal and hypopharyngeal cancer: value of imaging studies - Imaging methods assist in the pre-treatment planning of laryngeal and hypopharyngeal neoplasms, by better defining the local extension of infiltrating tumours and by detecting subclinical neck adenopathies. Imaging has also an important role in excluding or detecting distant metastasis. Furthermore, there is evidence that several imaging-derived parameters can be used as predictors of locoregional control after radiotherapy, and this independently from the TN classification.